Delivery Order SPE2DE24D0013-SPE2D625F2UZZ
- Not listed
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. Issued on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order (XPRS4PLEX-10) carries no set-aside designation and represents a short-term procurement under one of Cepheid's existing indefinite delivery vehicle contracts. The place of performance is Sunnyvale,...
- The U.S. Defense Department's Medical Supply Chain division awarded a $95,200 firm fixed-price delivery order to Cepheid Inc. on August 28, 2025, with final completion scheduled for September 5, 2025. This delivery order, designated XPRS4PLEX-10, carries no set-aside designation and represents work to be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic solutions, specializes in GeneXpert diagnostic systems and associated...
- The Defense Department's Medical Supply Chain awarded a $16.2K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 27, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the Department's procurement of diagnostic testing capabilities through Cepheid's established federal contracting vehicles. Cepheid specializes in...
- The U.S. Defense Department's Medical Supply Chain division awarded a $29,520 firm fixed-price delivery order to Cepheid Inc. on August 28, 2025, with an ultimate completion date of September 5, 2025. The contract, which carries no set-aside designation, is for molecular diagnostic solutions to be performed at Cepheid's facility in Sunnyvale, California. Cepheid, a for-profit manufacturer of advanced diagnostic systems and test kits, specializes in detecting infectious diseases and clinical...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $2,040 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, under contract XPRS4PLEX-10. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, represents a continuation of Cepheid's ongoing provision of diagnostic solutions to federal healthcare systems. The contract carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a $6,800 firm fixed-price delivery order (XPRS4PLEX-10) from the Defense Department's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 29, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies and test kits to federal defense and healthcare systems. This...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Department's Medical Supply Chain awarded a $1,925 firm fixed-price delivery order to Cepheid Inc. on August 13, 2025, with an ultimate completion date of August 20, 2025. The contract, identified as XPRSARS-COV2-10, represents a delivery order under a larger vehicle and carries no set-aside designation. Work will be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic solutions, specializes in advanced...
- The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2UZZDelivery Order
The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts, such as the Veterans Integrated Service Network 6 IDV valued at $32.8 million, which provides molecular diagnostic testing system reagents and assays through September 2030. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing, with a substantial track record delivering to federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency. The company's core offerings include GeneXpert diagnostic systems, molecular reagents, and test kits designed to detect conditions such as COVID-19, influenza, respiratory syncytial virus, and methicillin-resistant Staphylococcus aureus. This particular delivery order supports the federal government's ongoing medical supply chain requirements and aligns with the Defense Department's continued investment in diagnostic capabilities across its healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.4k | 9/8/25 |